Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. W. Wilker
Validation of the P21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
Cancer Research
Cancer Research
Oncology
Related publications
P21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2
PLoS ONE
Multidisciplinary
Pseudosubstrate Regulation of the Type II P21-Activated Kinases (PAKs)
Biophysical Journal
Biophysics
Neurofibromatosis Type 2
Neurology
Neurology
Inhibition of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation and Increases Survival of Mice With Pancreatic Cancer
International Journal of Cancer
Cancer Research
Oncology
Group I P21-Activated Kinases: Emerging Roles in Immune Function and Viral Pathogenesis
International Journal of Biochemistry and Cell Biology
Biochemistry
Cell Biology
Expression of P21-Activated Kinases 1 and 3 Is Altered in the Brain of Subjects With Depression
Neuroscience
Neuroscience
Inhibition or Ablation of P21-Activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanismsin Vivo
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Inhibition of P21-Activated Kinase 4 Expression Suppresses the Proliferation of Hep-2 Laryngeal Carcinoma Cells via Activation of the ATM/Chk1/2/p53 Pathway
International Journal of Oncology
Cancer Research
Oncology
Mitogen-Activated Protein Kinases as Glucose Transducers for Diabetic Complications
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
